Showing 51 - 60 of 41,743
Poor quality essential medicines, both substandard and counterfeit, are serious but neglected public health problems. Anti-infective medicines are particularly afflicted. Unfortunately, attempts to improve medicine quality have been hampered by confusion and controversy over definitions. For...
Persistent link: https://www.econbiz.de/10009393988
This paper extracts the policy implications from ENEPRI Research Report Nos. 28, entitled Health and Morbidity in the …
Persistent link: https://www.econbiz.de/10014173213
Persistent link: https://www.econbiz.de/10012216184
Persistent link: https://www.econbiz.de/10011704230
The main purpose of this work is to develop a case study assessing the recent patterns and impacts of ODA (official development assistance) and DAH (development assistance for health) to Liberia on overall government spending and domestic revenue generation as well as domestic government health...
Persistent link: https://www.econbiz.de/10010775388
Persistent link: https://www.econbiz.de/10013445319
Persistent link: https://www.econbiz.de/10013445365
Persistent link: https://www.econbiz.de/10001554485
Samoa currently faces two important public policy challenges in the health sector. One is to stem, and then reverse, the rapid rise of non-communicable diseases (NCDs). The second challenge is to put the country on a health-financing path that is effective, efficient, and financially affordable...
Persistent link: https://www.econbiz.de/10010932945
Indonesia launched the national health insurance program - Jaminan Kesehatan National (JKN), on January 1, 2014, and aims to achieve universal health coverage (UHC) by 2019. Achieving UHC means not only increasing the number of people covered but also expanding the benefits package and ensuring...
Persistent link: https://www.econbiz.de/10010937834